Case series showing the safety and changes in lipid profiles of hemodialysis patients with hypertriglyceridemia after pemafibrate administration

Rino Okada, Yasuhiro Onishi, Naoya Kobayashi, Hiroyuki Ishihara, Tomohisa Yokoyama, Tomoyo Mifune, Yoshimasa Sakurabu, Ichiro Nojima, Hiroshi Morinaga, Haruhito A. Uchida, Jun Wada

Open source

DOI
10.1186/s41100-024-00590-8
Published
12
Container
Renal Replacement Therapy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s41100-024-00590-8,
  title = {Case series showing the safety and changes in lipid profiles of hemodialysis patients with hypertriglyceridemia after pemafibrate administration},
  author = {Rino Okada and Yasuhiro Onishi and Naoya Kobayashi and Hiroyuki Ishihara and Tomohisa Yokoyama and Tomoyo Mifune and Yoshimasa Sakurabu and Ichiro Nojima and Hiroshi Morinaga and Haruhito A. Uchida and Jun Wada},
  year = {2024},
  journal = {Renal Replacement Therapy},
  doi = {10.1186/s41100-024-00590-8},
  url = {https://doi.org/10.1186/s41100-024-00590-8}
}

RIS

TY  - JOUR
TI  - Case series showing the safety and changes in lipid profiles of hemodialysis patients with hypertriglyceridemia after pemafibrate administration
AU  - Rino Okada
AU  - Yasuhiro Onishi
AU  - Naoya Kobayashi
AU  - Hiroyuki Ishihara
AU  - Tomohisa Yokoyama
AU  - Tomoyo Mifune
AU  - Yoshimasa Sakurabu
AU  - Ichiro Nojima
AU  - Hiroshi Morinaga
AU  - Haruhito A. Uchida
AU  - Jun Wada
PY  - 2024
JO  - Renal Replacement Therapy
DO  - 10.1186/s41100-024-00590-8
UR  - https://doi.org/10.1186/s41100-024-00590-8
ER  - 

APA

Okada, R., Onishi, Y., Kobayashi, N., Ishihara, H., Yokoyama, T., Mifune, T., Sakurabu, Y., Nojima, I., Morinaga, H., Uchida, H. A., & Wada, J. (2024). Case series showing the safety and changes in lipid profiles of hemodialysis patients with hypertriglyceridemia after pemafibrate administration. Renal Replacement Therapy. https://doi.org/10.1186/s41100-024-00590-8

Source records